Science Explorer Back to mapMap

Most cited papers from Enanta Pharmaceuticals (United States)

What are the most cited papers from Enanta Pharmaceuticals (United States)?

The most cited paper from Enanta Pharmaceuticals (United States) is "Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays" (Andrew N. Hoofnagle et al., 2015), with 238 citations. Next come "Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways" (210) and "EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study" (118).

Showing 50 of 86 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry–Based Assays Andrew N. Hoofnagle et al. · Clinical Chemistry Open access 30 Dec 2015 238
2 Papillomavirus E2 induces senescence in HPV‐positive cells via pRB‐ and p21CIP‐dependent pathways Susanne I. Wells, Delicia A. Francis, Alla Y. Karpova et al. · The EMBO Journal Open access Nov 2000 210
3 EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study Vlad Ratziu, Mary Eugenia Rinella, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology Open access 2 Nov 2021 118
4 In Vitro and In Vivo Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450 Tami Pilot-Matias, Rakesh L. Tripathi, Daniel E. Cohen et al. · Antimicrobial Agents and Chemotherapy Open access 2 Dec 2014 117
5 Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling Shaoguang Li, Anthony D. Couvillon, Bradley B. Brasher et al. · The EMBO Journal Open access 3 Dec 2001 106
6 CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes Anna M. Ericsson, Marcus Svensson, Anu Arya et al. · European Journal of Immunology Open access 5 Aug 2004 104
7 In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir Teresa I. Ng, Rakesh L. Tripathi, Thomas J. Reisch et al. · Antimicrobial Agents and Chemotherapy Open access 30 Oct 2017 91
8 The αvintegrin antagonists as novel anticancer agents: an update Janet S. Kerr, Andrew Slee, Shaker A. Mousa · Expert Opinion on Investigational Drugs Dec 2002 65
9 Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist Derek J. Erstad et al. · Hepatology Communications Open access 21 May 2018 60
10 Binding Site of the Bridged Macrolides in the Escherichia coli Ribosome Liqun Xiong, Yakov Korkhin, Alexander S. Mankin · Antimicrobial Agents and Chemotherapy Open access 23 Dec 2004 60
11 10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS Y. Benhamou, Joseph Moussalli, Vlad Ratziu et al. · Journal of Hepatology Open access Apr 2009 58
12 Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain Bradley B. Brasher, Sergei A. Roumiantsev, Richard A. Van Etten · Oncogene Open access 22 Nov 2001 55
13 A novel non‐bile acid FXR agonist EDP‐305 potently suppresses liver injury and fibrosis without worsening of ductular reaction Ping An, Guangyan Wei, Pinzhu Huang et al. · Liver International Open access 24 Apr 2020 54
14 Synthesis of Novel 6,11-O-Bridged Bicyclic Ketolides via a Palladium-Catalyzed Bis-allylation Guoqiang Wang, Deqiang Niu, Yao‐Ling Qiu et al. · Organic Letters 26 Oct 2004 46
15 EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate model Michael H. J. Rhodin, Nicole McAllister, Jonathan Castillo et al. · PLoS Pathogens Open access 15 Mar 2021 45
16 Characterization of Mutations in NOT2 Indicates that it Plays an Important Role in Maintaining the Integrity of the CCR4–NOT Complex Pamela Joan Russell, John D. Benson, Clyde L. Denis · Journal of Molecular Biology Sep 2002 40
17 Cdc25 as a Potential Target of Anticancer Agents Jens W. Eckstein · Investigational New Drugs May 2000 40
18 Development of a Ubiquitin Transfer Assay for High Throughput Screening by Fluorescence Resonance Energy Transfer Michael D. Boisclair, Christopher McClure, Serene Josiah et al. · SLAS DISCOVERY Open access Oct 2000 39
19 Synthesis and Antibacterial Activity of a Novel Class of 4‘-Substituted 16-Membered Ring Macrolides Derived from Tylosin Ly Phan, Tianying Jian, Zhigang Chen et al. · Journal of Medicinal Chemistry 4 May 2004 37
20 The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction Li Shen, Sarani Ghoshal, Mozhdeh Sojoodi et al. · The FASEB Journal Open access 18 Mar 2019 36
21 The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivo Michael H. J. Rhodin et al. · Nature Communications Open access Aug 2024 34
22 Reassessing the effects of histone deacetylase inhibitors on hippocampal memory and cognitive aging James F. Castellano, Bonnie R. Fletcher, Holger Patzke et al. · Hippocampus Open access 17 Apr 2014 30
23 Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: Length optimization and zero carbon linker oximes Datong Tang, Yonghua Gai, Alexander Polemeropoulos et al. · Bioorganic & Medicinal Chemistry Letters 4 Aug 2008 29
24 The Efficacy of Clarithromycin and the Bicyclolide EDP‐420 againstMycobacterium aviumin a Mouse Model of Pulmonary Infection Luiz Eduardo Bermudez, Nima Motamedi, Peter Kolonoski et al. · The Journal of Infectious Diseases 18 Apr 2008 27
25 An Efficient Large-Scale Synthesis of EDP-420, a First-in-Class Bridged Bicyclic Macrolide (BBM) Antibiotic Drug Candidate Guoyou Xu, Datong Tang, Yonghua Gai et al. · Organic Process Research & Development 3 May 2010 26
26 Oxazoles Vince S. C. Yeh, Radha Iyengar · Elsevier eBooks Book chapter 2008 24
27 Recent Advances in Developing Antiviral Therapies for Respiratory Syncytial Virus Brian C. Shook, Kai Wei Lin · Topics in Current Chemistry 21 Mar 2017 22
28 A new class of cyclosporin analogues for the treatment of asthma Jens W. Eckstein, John J. Fung · Expert Opinion on Investigational Drugs Apr 2003 22
29 Synthesis and Biological Evaluation of Novel Cyclosporin A Analogues: Potential Soft Drugs for the Treatment of Autoimmune Diseases Tsvetelina I. Lazarova, Jason S. Chen, Blake C. Hamann et al. · Journal of Medicinal Chemistry Open access 29 Jan 2003 21
30 Synthesis of New 14-Membered Macrolide Antibiotics via a Novel Ring Contraction Metathesis Tsvetelina I. Lazarova, Sophie M. Binet, Nha Huu Vo et al. · Organic Letters 25 Jan 2003 20
31 In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains Susanne Jacobsson, Daniel Golparian, Ly Phan et al. · Journal of Antimicrobial Chemotherapy Open access Sep 2014 17
32 Recent Advances in the Medicinal Chemistry of Novel Erythromycin- Derivatized Antibiotics Lu Ying, Datong Tang · Current Topics in Medicinal Chemistry 14 Aug 2010 17
33 EDP-420, a Bicyclolide (Bridged Bicyclic Macrolide), Is Active against Mycobacterium avium Luiz Eduardo Bermudez, Nima Motamedi, Christopher B. Chee et al. · Antimicrobial Agents and Chemotherapy Open access 13 Feb 2007 15
34 The Discovery and Development of HCV NS3 Protease Inhibitor Paritaprevir Keith F. McDaniel, Yi‐Yin Ku, Ying Hui Sun et al. · Topics in medicinal chemistry Book chapter 2019 14
35 Volatile Compounds of Tufted Hairgrass Eric Watkins, Thomas J. Gianfagna, Rongqi Sun et al. · Crop Science Nov 2006 14
36 EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B Jordan J. Feld, Eric Lawitz, Tuan Nguyen et al. · Antiviral Therapy Open access 15 Nov 2022 13
37 Discovery and Development of the Next-Generation HCV NS3 Protease Inhibitor Glecaprevir Guoqiang Wang, Jun Ma, Lijuan Jiang et al. · Topics in medicinal chemistry Book chapter 2019 13
38 CCL25 Enhances CD103‐Mediated Lymphocyte Adhesion to E‐Cadherin Anna M. Ericsson, Anu Arya, William W. Agace · Annals of the New York Academy of Sciences Dec 2004 13
39 Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model A. Stucki, Peter Arne Gerber, Félix Acosta et al. · Journal of Antimicrobial Chemotherapy Open access 26 Jan 2008 13
40 Synthesis of 3,6-bicyclolides: A novel class of macrolide antibiotics Yonghua Gai, Datong Tang, Guoyou Xu et al. · Bioorganic & Medicinal Chemistry Letters Nov 2008 13
41 Fragmentation of peptides with intra-chain disulfide bonds in triple quadrupole mass spectrometry and its quantitative application to biological samples Yun Chen, Shanlei Qiao, Ce Wang · International Journal of Mass Spectrometry Sep 2009 12
42 Conformational Analysis of a Stereochemically Complete Set of Cis-enediol Peptide Analogues Olivier Alain Michielin, Vincent Zoete, Tiffany Malinky Gierasch et al. · Journal of the American Chemical Society 23 Aug 2002 11
43 EDP ‐323, a First‐In‐Class, Once‐Daily, Oral L‐Protein Inhibitor for the Treatment of RSV : Results From a Phase 1 Study in Healthy Adults Kimberly Elmore, John P. DeVincenzo, Michael H. J. Rhodin et al. · Clinical and Translational Science Open access 28 Apr 2025 10
44 Integrated version of reverse two-hybrid system for the postproteomic era Hideki Endoh, Sylvie Vincent, Yves Jacob et al. · Methods in enzymology on CD-ROM/Methods in enzymology Book chapter 2002 10
45 Molecular Basis for Antiviral Action of EDP‐235: A Potent and Selective SARS‐CoV‐2 3CLpro Inhibitor for the Treatment of Covid 19 Anand Setty Balakrishnan, Archie Reyes, Ruichao Shen et al. · The FASEB Journal Open access May 2022 9
46 Reproducible lung protective effects of a TGFβR1/ALK5 inhibitor in a bleomycin‐induced and spirometry‐confirmed model of IPF in male mice Asbjørn Graver Petersen, Stefanie H. Korntner, Jamal Bousamaki et al. · Physiological Reports Open access Oct 2024 8
47 Pharmacokinetics of EDP-420 after Ascending Single Oral Doses in Healthy Adult Volunteers Lijuan Jiang, Michelle Wang, Yat Sun Or · Antimicrobial Agents and Chemotherapy Open access 18 Feb 2009 8
48 Synthesis of novel 4′-substituted 16-membered ring macrolide antibiotics derived from leucomycins Zhaolin Wang, Tianying Jian, Ly Phan et al. · Bioorganic & Medicinal Chemistry Letters 5 Dec 2003 8
49 EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus Rachel Emily Levene, John P. DeVincenzo, Annie L. Conery et al. · The Journal of Infectious Diseases Open access 23 Sep 2024 7
50 Pharmacokinetics of EDP-420 after Multiple Oral Doses in Healthy Adult Volunteers and in a Bioequivalence Study Lijuan Jiang, Yat Sun Or · Antimicrobial Agents and Chemotherapy Open access 19 May 2009 7

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.